Early research (Phase 1)Study completedNCT01235416
What this trial is testing
A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors
Who this might be right for
Histologically or Cytologically Documented Solid Tumors
Amgen 57